Quantinno Capital Management LP Purchases 4,916 Shares of Waters Co. (NYSE:WAT)

Quantinno Capital Management LP boosted its stake in Waters Co. (NYSE:WAT - Free Report) by 19.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 29,711 shares of the medical instruments supplier's stock after purchasing an additional 4,916 shares during the quarter. Quantinno Capital Management LP owned approximately 0.05% of Waters worth $11,022,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in the stock. Mufg Securities Americas Inc. bought a new position in Waters in the 4th quarter worth about $325,000. MainStreet Investment Advisors LLC boosted its stake in Waters by 1.2% in the 4th quarter. MainStreet Investment Advisors LLC now owns 3,381 shares of the medical instruments supplier's stock worth $1,254,000 after purchasing an additional 40 shares during the period. Man Group plc boosted its stake in Waters by 45.6% in the 4th quarter. Man Group plc now owns 52,363 shares of the medical instruments supplier's stock worth $19,426,000 after purchasing an additional 16,391 shares during the period. Nomura Holdings Inc. bought a new position in Waters in the 4th quarter worth about $726,000. Finally, NorthRock Partners LLC bought a new position in Waters in the 4th quarter worth about $404,000. Institutional investors own 94.01% of the company's stock.

Analyst Ratings Changes

Several analysts have weighed in on WAT shares. UBS Group lowered their price target on Waters from $415.00 to $360.00 and set a "neutral" rating on the stock in a report on Wednesday, May 7th. Barclays lowered their price target on Waters from $400.00 to $350.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. KeyCorp raised Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 price target on the stock in a report on Monday, March 31st. StockNews.com cut Waters from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. Finally, Robert W. Baird raised their price target on Waters from $355.00 to $374.00 and gave the company an "outperform" rating in a report on Wednesday, May 7th. Ten analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $390.19.

Waters Trading Up 2.2%

Waters stock traded up $7.78 during trading hours on Friday, reaching $359.38. The company had a trading volume of 364,333 shares, compared to its average volume of 478,095. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65. The company has a 50-day moving average price of $346.71 and a 200 day moving average price of $371.19. The firm has a market cap of $21.39 billion, a price-to-earnings ratio of 33.56, a P/E/G ratio of 3.79 and a beta of 1.14. Waters Co. has a 12-month low of $279.24 and a 12-month high of $423.56.

Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The medical instruments supplier reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $2.22 by $0.03. The business had revenue of $661.71 million for the quarter, compared to analysts' expectations of $655.50 million. Waters had a return on equity of 46.31% and a net margin of 21.56%. The business's quarterly revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the firm earned $2.21 EPS. Equities analysts forecast that Waters Co. will post 12.86 earnings per share for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.